Clinical trial
Establishment a Nucleic Acid Rapid Detection Technology Platform for Detecting Pathogenic Bordetella and Its Drug Resistance Genes
NCT04535505 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Establishment a Nucleic Acid Rapid Detection Technology Platform for Detecting Pathogenic Bordetella and Its Drug Resistance Genes
- Lead sponsor
- Children's Hospital of Fudan University
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 31, 2022
- Completion date
- December 31, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pertussis